Ester Blanco

18PUBLICATIONS
43CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Agricultural molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 10, 2024
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra

|Jun 28, 2023
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.

Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio

|Jun 27, 2023
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.

Ana Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona

|Mar 29, 2023
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.

Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra

|Feb 11, 2023
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors.

Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio

|Jan 06, 2023
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth.

Oihane Erice, Shruthi Narayanan, Iker Feliu

Pageof 3

Frequent Collaborators

14 joint publications

Ana Isabel Bocanegra

13 joint publications

Hugo Arasanz

11 joint publications

Luisa Chocarro

11 joint publications

David Escors